Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Current and future state of FDA-CMS parallel reviews.
Messner DA, Tunis SR. Messner DA, et al. Among authors: tunis sr. Clin Pharmacol Ther. 2012 Mar;91(3):383-5. doi: 10.1038/clpt.2011.350. Clin Pharmacol Ther. 2012. PMID: 22343814
Accelerated access to innovative medicines for patients in need.
Baird LG, Banken R, Eichler HG, Kristensen FB, Lee DK, Lim JC, Lim R, Longson C, Pezalla E, Salmonson T, Samaha D, Tunis S, Woodcock J, Hirsch G. Baird LG, et al. Clin Pharmacol Ther. 2014 Nov;96(5):559-71. doi: 10.1038/clpt.2014.145. Epub 2014 Jul 9. Clin Pharmacol Ther. 2014. PMID: 25006877
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients.
Eichler HG, Baird LG, Barker R, Bloechl-Daum B, Børlum-Kristensen F, Brown J, Chua R, Del Signore S, Dugan U, Ferguson J, Garner S, Goettsch W, Haigh J, Honig P, Hoos A, Huckle P, Kondo T, Le Cam Y, Leufkens H, Lim R, Longson C, Lumpkin M, Maraganore J, O'Rourke B, Oye K, Pezalla E, Pignatti F, Raine J, Rasi G, Salmonson T, Samaha D, Schneeweiss S, Siviero PD, Skinner M, Teagarden JR, Tominaga T, Trusheim MR, Tunis S, Unger TF, Vamvakas S, Hirsch G. Eichler HG, et al. Clin Pharmacol Ther. 2015 Mar;97(3):234-46. doi: 10.1002/cpt.59. Epub 2015 Feb 4. Clin Pharmacol Ther. 2015. PMID: 25669457 Free PMC article.
Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials.
Mullins CD, Whicher D, Reese ES, Tunis S. Mullins CD, et al. Pharmacoeconomics. 2010;28(10):969-76. doi: 10.2165/11536160-000000000-00000. Pharmacoeconomics. 2010. PMID: 20831305
Uncertainty in assessing value of oncology treatments.
Mullins CD, Montgomery R, Tunis S. Mullins CD, et al. Oncologist. 2010;15 Suppl 1:58-64. doi: 10.1634/theoncologist.2010-S1-58. Oncologist. 2010. PMID: 20237219
The National Oncologic PET Registry: lessons learned for coverage with evidence development.
Tunis S, Whicher D. Tunis S, et al. J Am Coll Radiol. 2009 May;6(5):360-5. doi: 10.1016/j.jacr.2009.01.016. J Am Coll Radiol. 2009. PMID: 19394577
Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research.
Tunis SR, Turkelson C. Tunis SR, et al. J Clin Oncol. 2012 Dec 1;30(34):4256-61. doi: 10.1200/JCO.2012.42.6338. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071248 Review.
Medical and pharmacy coverage decision making at the population level.
Mohr PE, Tunis SR. Mohr PE, et al. Among authors: tunis sr. J Manag Care Spec Pharm. 2014 Jun;20(6):547-54. doi: 10.18553/jmcp.2014.20.6.547. J Manag Care Spec Pharm. 2014. PMID: 24856592
Comparative effectiveness research: Policy context, methods development and research infrastructure.
Tunis SR, Benner J, McClellan M. Tunis SR, et al. Stat Med. 2010 Aug 30;29(19):1963-76. doi: 10.1002/sim.3818. Stat Med. 2010. PMID: 20564311
Levers for addressing medical underuse and overuse: achieving high-value health care.
Elshaug AG, Rosenthal MB, Lavis JN, Brownlee S, Schmidt H, Nagpal S, Littlejohns P, Srivastava D, Tunis S, Saini V. Elshaug AG, et al. Lancet. 2017 Jul 8;390(10090):191-202. doi: 10.1016/S0140-6736(16)32586-7. Epub 2017 Jan 9. Lancet. 2017. PMID: 28077228 Review.
63 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback